Single center experience with Hypotension Prediction Index (HPI) during cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Saved in:
Main Authors: | Camilla L’Acqua, Luciano Frassanito, Shigeki Kusamura, Franco Valenza |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Anesthesia, Analgesia and Critical Care |
Online Access: | https://doi.org/10.1186/s44158-025-00225-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperthermic intraperitoneal chemotherapy (HIPEC) increases risk of local anesthetic systemic toxicity (LAST)
by: Masahiko Tsuchiya, et al.
Published: (2025-01-01) -
Morbidity and Mortality Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy at a Single Institution in Japan
by: Akiyoshi Mizumoto, et al.
Published: (2012-01-01) -
Hyperthermic intraperitoneal chemotherapy: Ideal and reality
by: Fan-He Dong, et al.
Published: (2025-02-01) -
Changes in Hepatic Blood Flow and Liver Function during Closed Abdominal Hyperthermic Intraperitoneal Chemotherapy following Cytoreduction Surgery
by: Stéphanie Dupont, et al.
Published: (2018-01-01) -
Risk factors for postoperative acute kidney injury after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta-analysis and systematic review
by: Dengzhuo Chen, et al.
Published: (2025-02-01)